Your browser doesn't support javascript.
loading
Evaluation of in-vitro susceptibility of ß-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil
Carvalho, Thaisa Noceti; Kobs, Vanessa Cristine; Hille, Daniela; Deglmann, Roseneide Campos; Melo, Luiz Henrique; França, Paulo Henrique Condeixa de.
Afiliación
  • Carvalho, Thaisa Noceti; Universidade da Região de Joinville. Joinville. BR
  • Kobs, Vanessa Cristine; Universidade da Região de Joinville. Joinville. BR
  • Hille, Daniela; Universidade da Região de Joinville. Joinville. BR
  • Deglmann, Roseneide Campos; Universidade da Região de Joinville. Joinville. BR
  • Melo, Luiz Henrique; Universidade da Região de Joinville. Joinville. BR
  • França, Paulo Henrique Condeixa de; Universidade da Região de Joinville. Joinville. BR
Rev. Soc. Bras. Med. Trop ; Rev. Soc. Bras. Med. Trop;56: e0277, 2023. tab, graf
Article en En | LILACS-Express | LILACS | ID: biblio-1422902
Biblioteca responsable: BR1.1
ABSTRACT
ABSTRACT

Background:

The spread of carbapenemase- and extended-spectrum β-lactamase (ESBL)-producing gram-negative bacilli (GNB) represent a global public health threat that limits therapeutic options for hospitalized patients. This study aimed to evaluate the in-vitro susceptibility of β-lactam-resistant GNB to ceftazidime-avibactam (C/A) and ceftolozane-tazobactam (C/T), and investigate the molecular determinants of resistance.

Methods:

Overall, 101 clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected from a general hospital in Brazil were analyzed. Susceptibility to the antimicrobial agents was evaluated using an automated method, and the minimum inhibitory concentrations (MIC50/90) of C/A and C/T were determined using Etest®. The β-lactamase-encoding genes were investigated using polymerase chain reaction.

Results:

High susceptibility to C/A and C/T was observed among ESBL-producing Enterobacterales (100% and 97.3% for CLSI and 83.8% for BRCAST, respectively) and carbapenem-resistant P. aeruginosa (92.3% and 87.2%, respectively). Carbapenemase-producing Klebsiella pneumoniae exhibited high resistance to C/T (80%- CLSI or 100%- BRCAST) but high susceptibility to C/A (93.4%). All carbapenem-resistant K. pneumoniae isolates were susceptible to C/A, whereas only one isolate was susceptible to C/T. Both antimicrobials were inactive against metallo-β-lactamase-producing K. pneumoniae isolates. Resistance genes were concomitantly identified in 44 (44.9%) isolates, with bla CTX-M and bla SHV being the most common.

Conclusions:

C/A and C/T were active against microorganisms with β-lactam-resistant phenotypes, except when resistance was mediated by metallo-β-lactamases. Most C/A- and C/T-resistant isolates concomitantly carried two or more β-lactamase-encoding genes (62.5% and 77.4%, respectively).
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: LILACS País/Región como asunto: America do sul / Brasil Idioma: En Revista: Rev. Soc. Bras. Med. Trop Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article / Project document País de afiliación: Brasil Pais de publicación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: LILACS País/Región como asunto: America do sul / Brasil Idioma: En Revista: Rev. Soc. Bras. Med. Trop Asunto de la revista: MEDICINA TROPICAL Año: 2023 Tipo del documento: Article / Project document País de afiliación: Brasil Pais de publicación: Brasil